Shares of Johnson & Johnson (NYSE: JNJ) opened more than 3% higher on Wednesday after the company reported that 15 new tests from the same bottle of Johnson’s Baby Powder previously tested by the U.S. Food and Drug Administration (FDA) found no asbestos in the product.
The pharmaceutical giant said an additional 48 new laboratory tests of J&J’s baby powder recalled earlier this month confirmed the product does not contain the carcinogen.
“Rigorous and third-party testing confirms there is no asbestos in Johnson’s Baby Powder. We stand by the safety of our product,” the company said.
The New Brunswick, New Jersey-based company is facing a mountain of lawsuits claiming its talc-based baby powder contained asbestos, causing mesothelioma and ovarian cancer.
In previous talc trials, a St. Louis jury ordered J&J to pay USD 4.69 Billion to 22 women who alleged the company’s talc-based baby powder caused them to develop ovarian cancer. J&J is appealing the judgement and has won several other court cases alleging liability and damages.
Other recent verdicts ordered J&J to pay USD 325 Million and USD 25 Million to plaintiffs in California and New York, respectively.
The company is also facing securities lawsuits claiming it failed to disclose the alleged asbestos contamination in its baby powder, leading to billions worth of financial losses for investors from drops in the price of Johnson & Johnson’s stock.
52 week low/high
Retail0 Comments Shares of Home Depot, Inc. (NYSE: HD) are down about 5% on Tuesday after the company cut its 2019 forecast and reported same-store sales that fell short of estimates. Home Depot also posted revenue that missed analysts’ targets....
Retail0 Comments Shares of beauty giant Coty Inc. (NYSE: COTY) are up about 2% on Monday after the company announced it will take a majority stake in Kylie Cosmetics. The deal, expected to close in the third quarter of fiscal 2020, gives Coty a...
Retail0 Comments Shares of Tyson Foods, Inc. (NYSE: TSN) are up over 6% on Tuesday, even after the meat producer reported fourth quarter earnings and sales that fell short of estimates. Tyson said net sales increased 8.8% to USD 10.88 Billion....